Hyperphosphorylation of Tau Associates With Changes in Its Function Beyond Microtubule Stability

Alonso, 2016, Molecular mechanism of prion-like tau-induced neurodegeneration, Alzheimers Dement., 12, 1090, 10.1016/j.jalz.2015.12.014

Alonso, 2017, The tau misfolding pathway to dementia, Protein Folding Disorders in the Central Nervous System, 83, 10.1142/9789813222960_0004

Alonso, 2010, Phosphorylation of tau at Thr212, Thr231, and Ser262 combined causes neurodegeneration, J. Biol. Chem., 285, 30851, 10.1074/jbc.M110.110957

Alonso, 1996, Alzheimer’s disease hyperphosphorylated tau sequesters normal tau into tangles of filaments and disassembles microtubules, Nat. Med., 2, 783, 10.1038/nm0796-783

Alonso, 1997, Abnormal phosphorylation of tau and the mechanism of Alzheimer neurofibrillary degeneration: sequestration of microtubule-associated proteins 1 and 2 and the disassembly of microtubules by the abnormal tau, Proc. Natl. Acad. Sci. U S A, 94, 298, 10.1073/pnas.94.1.298

Alonso, 2006, Polymerization of hyperphosphorylated tau into filaments eliminates its inhibitory activity, Proc. Natl. Acad. Sci. U S A, 103, 8864, 10.1073/pnas.0603214103

Alonso, 2004, Promotion of hyperphosphorylation by frontotemporal dementia tau mutations, J. Biol. Chem., 279, 34873, 10.1074/jbc.M405131200

Alonso, 1994, Role of abnormally phosphorylated tau in the breakdown of microtubules in Alzheimer disease, Proc. Natl. Acad. Sci. U S A, 91, 5562, 10.1073/pnas.91.12.5562

Alonso, , Interaction of tau isoforms with Alzheimer’s disease abnormally hyperphosphorylated tau and in vitro phosphorylation into the disease-like protein, J. Biol. Chem., 276, 37967, 10.1074/jbc.M105365200

Alonso, , Hyperphosphorylation induces self-assembly of tau into tangles of paired helical filaments/straight filaments, Proc. Natl. Acad. Sci. U S A, 98, 6923, 10.1073/pnas.121119298

Andreadis, 2005, Tau gene alternative splicing: expression patterns, regulation and modulation of function in normal brain and neurodegenerative diseases, Biochim. Biophys. Acta, 1739, 91, 10.1016/j.bbadis.2004.08.010

Bancher, 1989, Accumulation of abnormally phosphorylated tau precedes the formation of neurofibrillary tangles in Alzheimer’s disease, Brain Res., 477, 90, 10.1016/0006-8993(89)91396-6

Baquero, 2015, Tau phosphorylation plays a role in mRNA 3′ end processing, Proceedings of the 4th Metabolism in Neurological Disease and 11th Brain Research Conference, Society for Neuroscience

Beharry, 2013, Expression of Alzheimer-like pathological human tau induces a behavioral motor and olfactory learning deficit in Drosophila melanogaster, J. Alzheimers Dis., 37, 539, 10.3233/jad-130617

Beharry, 2014, Tau-induced neurodegeneration: mechanisms and targets, Neurosci. Bull., 30, 346, 10.1007/s12264-013-1414-z

Berger, 2007, Accumulation of pathological tau species and memory loss in a conditional model of tauopathy, J. Neurosci., 27, 3650, 10.1523/JNEUROSCI.0587-07.2007

Bibow, 2011, Structural impact of proline-directed pseudophosphorylation at AT8, AT100, and PHF1 epitopes on 441-residue tau, J. Am. Chem. Soc., 133, 15842, 10.1021/ja205836j

Brady, 1995, Presence of tau in isolated nuclei from human brain, Neurobiol. Aging, 16, 479, 10.1016/0197-4580(95)00023-8

Bukar Maina, 2016, Nuclear tau and its potential role in Alzheimer’s disease, Biomolecules, 6, 9, 10.3390/biom6010009

Bunker, 2006, FTDP-17 mutations compromise the ability of tau to regulate microtubule dynamics in cells, J. Biol. Chem., 281, 11856, 10.1074/jbc.M509420200

Cash, 2003, Microtubule reduction in Alzheimer’s disease and aging is independent of tau filament formation, Am. J. Pathol., 162, 1623, 10.1016/S0002-9440(10)64296-4

Cevher, 2010, Nuclear deadenylation/polyadenylation factors regulate 3′ processing in response to DNA damage, EMBO J., 29, 1674, 10.1038/emboj.2010.59

Chung, 2001, Proapoptotic effects of tau cleavage product generated by caspase-3, Neurobiol. Dis., 8, 162, 10.1006/nbdi.2000.0335

Cohen, 2013, The microtubule-associated tau protein has intrinsic acetyltransferase activity, Nat. Struct. Mol. Biol., 20, 756, 10.1038/nsmb.2555

Connell, 2005, Quantitative analysis of tau isoform transcripts in sporadic tauopathies, Mol. Brain Res., 137, 104, 10.1016/j.molbrainres.2005.02.014

Corbo, 2011, Therapeutic targets in Alzheimer’s disease and related tauopathies, Prog. Mol. Biol. Transl. Sci., 98, 47, 10.1016/B978-0-12-385506-0.00002-8

Devany, 2013, Positive and negative feedback loops in the p53 and mRNA 3′ processing pathways, Proc. Natl. Acad. Sci. U S A, 110, 3351, 10.1073/pnas.1212533110

Di, 2016, Abnormal tau induces cognitive impairment through two different mechanisms: synaptic dysfunction and neuronal loss, Sci. Rep., 6, 20833, 10.1038/srep20833

Eckermann, 2007, The β-propensity of Tau determines aggregation and synaptic loss in inducible mouse models of tauopathy, J. Biol. Chem., 282, 31755, 10.1074/jbc.M705282200

Elie, 2015, Tau co-organizes dynamic microtubule and actin networks, Sci. Rep., 5, 9964, 10.1038/srep09964

Fitzpatrick, 2017, Cryo-EM structures of tau filaments from Alzheimer’s disease, Nature, 547, 185, 10.1038/nature23002

Flunkert, 2013, Elevated levels of soluble total and hyperphosphorylated tau result in early behavioral deficits and distinct changes in brain pathology in a new tau transgenic mouse model, Neurodegener. Dis., 11, 194, 10.1159/000338152

Frost, 2014, Tau promotes neurodegeneration through global chromatin relaxation, Nat. Neurosci., 17, 357, 10.1038/nn.3639

Gamblin, 2003, Caspase cleavage of tau: linking amyloid and neurofibrillary tangles in Alzheimer’s disease, Proc. Natl. Acad. Sci. U S A, 100, 10032, 10.1073/pnas.1630428100

Ganguly, 2015, Tau assembly: the dominant role of PHF6 (VQIVYK) in microtubule binding region repeat R3, J. Phys. Chem. B, 119, 4582, 10.1021/acs.jpcb.5b00175

Goedert, 1990, Expression of separate isoforms of human tau protein: correlation with the tau pattern in brain and effects on tubulin polymerization, EMBO J., 9, 4225, 10.1002/j.1460-2075.1990.tb07870.x

Goedert, 1999, Effects of frontotemporal dementia FTDP-17 mutations on heparin-induced assembly of tau filaments, FEBS Lett., 450, 306, 10.1016/s0014-5793(99)00508-6

Goedert, 1989, Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer’s disease, Neuron, 3, 519, 10.1016/0896-6273(89)90210-9

Gómez-Ramos, 2006, Extracellular tau is toxic to neuronal cells, FEBS Lett., 580, 4842, 10.1016/j.febslet.2006.07.078

Gómez-Ramos, 2008, Extracellular tau promotes intracellular calcium increase through M1 and M3 muscarinic receptors in neuronal cells, Mol. Cell. Neurosci., 37, 673, 10.1016/j.mcn.2007.12.010

Greenwood, 1995, Localization and in situ phosphorylation state of nuclear tau, Exp. Cell Res., 220, 332, 10.1006/excr.1995.1323

Guillozet-Bongaarts, 2005, Tau truncation during neurofibrillary tangle evolution in Alzheimer’s disease, Neurobiol. Aging, 26, 1015, 10.1016/j.neurobiolaging.2004.09.019

Han, 2009, Familial FTDP-17 missense mutations inhibit microtubule assembly-promoting activity of tau by increasing phosphorylation at Ser202 in vitro, J. Biol. Chem., 284, 13422, 10.1074/jbc.M901095200

Higuchi, 2002, Tau protein and tauopathy, Neuropsychopharmacology: The Fifth Generation of Progress, 1339

Himmler, 1989, Tau consists of a set of proteins with repeated C-terminal microtubule-binding domains and variable N-terminal domains, Mol. Cell. Biol., 9, 1381, 10.1128/mcb.9.4.1381

Hoover, 2010, Tau mislocalization to dendritic spines mediates synaptic dysfunction independently of neurodegeneration, Neuron, 68, 1067, 10.1016/j.neuron.2010.11.030

Hua, 2003, Tau could protect DNA double helix structure, Biochim. Biophys. Acta, 1645, 205, 10.1016/s1570-9639(02)00538-1

Hundelt, 2011, Altered phosphorylation but no neurodegeneration in a mouse model of tau hyperphosphorylation, Neurobiol. Aging, 32, 991, 10.1016/j.neurobiolaging.2009.06.007

Hutton, 1998, Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17, Nature, 393, 702, 10.1038/31508

Iqbal, 2018, Recent developments with tau-based drug discovery, Expert Opin. Drug Discov., 13, 399, 10.1080/17460441.2018.1445084

Jicha, 1999, Altered conformation of recombinant frontotemporal dementia-17 mutant tau proteins, Neurosci. Lett., 260, 153, 10.1016/s0304-3940(98)00980-x

Kimura, 2007, Hyperphosphorylated tau in parahippocampal cortex impairs place learning in aged mice expressing wild-type human tau, EMBO J., 26, 5143, 10.1038/sj.emboj.7601917

Kopke, 1993, Microtubule-associated protein tau. Abnormal phosphorylation of a non-paired helical filament pool in Alzheimer disease, J. Biol. Chem., 268, 24374, 10.1016/S0021-9258(20)80536-5

Lasagna-Reeves, 2011, Tau oligomers impair memory and induce synaptic and mitochondrial dysfunction in wild-type mice, Mol. Neurodegener., 6, 39, 10.1186/1750-1326-6-39

Lewis, 2001, Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP, Science, 293, 1487, 10.1126/science.1058189

Lewis, 2000, Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein, Nat. Genet., 25, 402, 10.1038/78078

Mondragón-Rodríguez, , Cleavage and conformational changes of tau protein follow phosphorylation during Alzheimer’s disease, Int. J. Exp. Pathol., 89, 81, 10.1111/j.1365-2613.2007.00568.x

Mondragón-Rodríguez, , Conformational changes and cleavage of tau in Pick bodies parallel the early processing of tau found in Alzheimer pathology, Neuropathol. Appl. Neurobiol., 34, 62, 10.1111/j.1365-2990.2007.00853.x

Morozova, 2017, Receptor Mediated Prion-Like Propagation of PH-Tau.

Mudher, 2017, What is the evidence that tau pathology spreads through prion-like propagation?, Acta Neuropathol. Commun., 5, 99, 10.1186/s40478-017-0488-7

Multhaup, 2015, Amyloid precursor protein (APP) metabolites APP intracellular fragment (AICD), Aβ42, and Tau in nuclear roles, J. Biol. Chem., 290, 23515, 10.1074/jbc.r115.677211

Padmaraju, 2010, New evidences on Tau-DNA interactions and relevance to neurodegeneration, Neurochem. Int., 57, 51, 10.1016/j.neuint.2010.04.013

Pérez, 2001, In vitro assembly of tau protein: mapping the regions involved in filament formation, Biochemistry, 40, 5983, 10.1021/bi002961w

Poorkaj, 1998, Tau is a candidate gene for chromosome 17 frontotemporal dementia, Ann. Neurol., 43, 815, 10.1002/ana.410430617

Qi, 2015, Nuclear magnetic resonance spectroscopy characterization of interaction of Tau with DNA and its regulation by phosphorylation, Biochemistry, 54, 1525, 10.1021/bi5014613

Roberson, 2011, Amyloid-β/Fyn-induced synaptic, network and cognitive impairments depend on tau levels in multiple mouse models of Alzheimer’s disease, J. Neurosci., 31, 700, 10.1523/JNEUROSCI.4152-10.2011

Santacruz, 2005, Tau suppression in a neurodegenerative mouse model improves memory function, Science, 309, 476, 10.1126/science.1113694

Santa-María, 2005, Effect of quinones on microtubule polymerization: a link between oxidative stress and cytoskeletal alterations in Alzheimer’s disease, Biochim. Biophys. Acta, 1740, 472, 10.1016/j.bbadis.2004.11.024

Schindowski, 2006, Alzheimer’s disease-like tau neuropathology leads to memory deficits and loss of functional synapses in a novel mutated tau transgenic mouse without any motor deficits, Am. J. Pathol., 169, 599, 10.2353/ajpath.2006.060002

Schneider, 1999, Phosphorylation that detaches tau protein from microtubules (Ser262, Ser214) also protects it against aggregation into Alzheimer paired helical filaments, Biochemistry, 38, 3549, 10.1021/bi981874p

Spillantini, 1998, Mutation in the tau gene in familial multiple system tauopathy with presenile dementia, Proc. Natl. Acad. Sci. U S A, 95, 7737, 10.1073/pnas.95.13.7737

Sultan, 2011, Nuclear tau, a key player in neuronal DNA protection, J. Biol. Chem., 286, 4566, 10.1074/jbc.M110.199976

Sydow, 2011, Tau-induced defects in synaptic plasticity, learning and memory are reversible in transgenic mice after switching off the toxic Tau mutant, J. Neurosci., 31, 2511, 10.1523/JNEUROSCI.5245-10.2011

Tanemura, 2001, Formation of filamentous tau aggregations in transgenic mice expressing V337M human tau, Neurobiol. Dis., 8, 1036, 10.1006/nbdi.2001.0439

Tanemura, 2002, Neurodegeneration with tau accumulation in a transgenic mouse expressing V337M human tau, J. Neurosci., 22, 133, 10.1523/JNEUROSCI.22-01-00133.2002

Tatebayashi, 2002, Tau filament formation and associative memory deficit in aged mice expressing mutant (R406W) human tau, Proc. Natl. Acad. Sci. U S A, 99, 13896, 10.1073/pnas.202205599

Vandebroek, 2005, Identification and isolation of a hyperphosphorylated, conformationally changed intermediate of human protein tau expressed in yeast, Biochemistry, 44, 11466, 10.1021/bi0506775

von Bergen, 2000, Assembly of tau protein into Alzheimer paired helical filaments depends on a local sequence motif (306VQIVYK311) forming β structure, Proc. Natl. Acad. Sci. U S A, 97, 5129, 10.1073/pnas.97.10.5129

Webster, 2014, Using mice to model Alzheimer’s dementia: an overview of the clinical disease and the preclinical behavioral changes in 10 mouse models, Front. Genet., 5, 88, 10.3389/fgene.2014.00088

Wei, 2008, Binding to the minor groove of the double-strand, tau protein prevents DNA from damage by peroxidation, PLoS One, 3, e2600, 10.1371/journal.pone.0002600

Weingarten, 1975, A protein factor essential for microtubule assembly, Proc. Natl. Acad. Sci. U S A, 72, 1858, 10.1073/pnas.72.5.1858

Yoshiyama, 2007, Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model, Neuron, 53, 337, 10.1016/j.neuron.2007.01.010

Zhou, 2018, Relevance of phosphorylation and truncation of tau to the etiopathogenesis of Alzheimer’s disease, Front. Aging Neurosci., 10, 27, 10.3389/fnagi.2018.00027